{
    "Trade/Device Name(s)": [
        "QIAstat-Dx Respiratory Panel Plus"
    ],
    "Submitter Information": "QIAGEN GmbH",
    "510(k) Number": "K233100",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN200031",
        "K183597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF"
    ],
    "Summary Letter Date": "September 26, 2023",
    "Summary Letter Received Date": "September 26, 2023",
    "Submission Date": "May 08, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-Cov-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Adenovirus",
        "Human Coronavirus 229E",
        "Human Coronavirus HKU1",
        "Human Coronavirus NL63",
        "Human Coronavirus OC43",
        "Human Metapneumovirus",
        "Influenza A",
        "Influenza A H1",
        "Influenza A H1N1 pdm09",
        "Influenza A H3",
        "Influenza B",
        "Parainfluenza virus 1",
        "Parainfluenza virus 2",
        "Parainfluenza virus 3",
        "Parainfluenza virus 4",
        "Respiratory Syncytial Virus",
        "Human Rhinovirus/Enterovirus",
        "Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2)",
        "Bordetella pertussis",
        "Chlamydophila pneumoniae",
        "Mycoplasma pneumoniae"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab (NPS)"
    ],
    "Specimen Container(s)": [
        "Universal Transport Media (UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "QIAstat-Dx Analyzer 1.0",
        "QIAstat-Dx system"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time multiplex PCR (rtPCR)",
        "Nucleic acid extraction (spin columns)",
        "Microfluidics"
    ],
    "Methodologies": [
        "Multiplex RT-PCR",
        "Automated sample preparation",
        "Qualitative nucleic acid detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Panel",
        "Cartridge",
        "Multiplex",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for QIAstat-Dx Respiratory Panel Plus multiplex PCR assay for detection of respiratory viral and bacterial nucleic acids including SARS-CoV-2 using nasopharyngeal swabs.",
    "Indications for Use Summary": "Qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs from individuals with clinical signs and symptoms of respiratory tract infection, including SARS-CoV-2, using the QIAstat-Dx system.",
    "fda_folder": "Microbiology"
}